Helge Möllmann

Helge Möllmann

Interventional cardiologist / Cardiologist
St.-Johannes-Hospitals - Dortmund, Germany

Latest contributions

TAVI versus SAVR in aortic stenosis, is the debate still relevant in 2026?

02 Jun 2026

In this discussion, Helge Möllman and Eberhard Grube revisit the ongoing debate between TAVI and surgery in the treatment of aortic stenosis. While TAVI continues to expand into younger and more complex patient populations, they emphasise that the dialogue with cardiac surgery remains essential. They highlight the importance...

TAVI versus SAVR in aortic stenosis, is the debate still relevant in 2026?

The continuum of valvular heart disease: a lifetime management approach

21 May 2026 – From EuroPCR 2026

This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...

The continuum of valvular heart disease: a lifetime management approach

TAVI procedural challenges

21 May 2026 – From EuroPCR 2026

This session examines procedural challenges encountered during Transcatheter Aortic Valve Implantation (TAVI), especially in complex anatomical and clinical contexts. Topics include TAVI after prior mitral valve procedures, combined use of left ventricular assist devices and rotablation, navigating challenging aortic anatomies, and managing extensive calcification. The session...

Managing difficult TAVI scenarios

19 May 2026 – From EuroPCR 2026

Focused on complex TAVI cases, this session reviews guideline recommendations for TAVI in younger patients, strategies for managing concomitant coronary artery disease, and considerations for treating asymptomatic severe aortic stenosis. Real-world cases illustrate clinical decision-making and outcomes.

Managing difficult TAVI scenarios

Beyond the horizon - A prelude into TAVI and complex PCI solutions

19 May 2026 – From EuroPCR 2026

This session provides a comprehensive preview of evolving technologies and strategies shaping interventional cardiology. Discover the Myval Octapro+ transcatheter heart valve (THV) and its innovative design and procedural benefits demonstrated through a recorded case. Stay updated on Landmark and Compare TAVI trial data, and discover the...

Beyond the horizon - A prelude into TAVI and complex PCI solutions

Overcoming complexity in TAVI: a patient-centered approach

12 Jan 2026

Discover how to overcome complexity in TAVI, in this replay featuring H. Möllmann and guests R. Hahn, W-K. Kim and P. Lauten.

Valve selection in urgent TAVI: evidence from small annulus studies - Hotline

16 Nov 2025 – From PCR London Valves 2025

This session presents cutting-edge research comparing self-expanding and balloon-expandable valves in urgent and emergent TAVI settings, with a focus on small aortic annuli. It includes data from the NAVULTRA and LANDMARK trials, featuring novel biomimetic balloon-expandable valves and early feasibility studies that shed light on valve...

Hotline - TAVI - Part 2

TAVI-in-TAVI

16 Nov 2025 – From PCR London Valves 2025

This session explores the nuanced field of TAVI-in-TAVI procedures, focusing on valve durability considerations between bovine and porcine valves, strategies for redo TAVI post valve-in-valve, and advanced interventions to secure coronary flow such as inter-valvular stenting. It highlights complex anatomical challenges including aberrant coronary origins and...

Are we undertreating aortic regurgitation?

20 May 2025 – From EuroPCR 2025

At EuroPCR 2025, Victoria Delgado, Helge Möllmann, and Dan Blackman gather to discuss a crucial but often under-addressed challenge in structural heart disease: the under-referral and under-treatment of patients with aortic regurgitation (AR).

The conversation begins with the diagnostic challenges surrounding severe AR, followed by a striking observation—only...

Are we undertreating aortic regurgitation?

Management of complex left main trifurcation lesion

22 May 2025 – From EuroPCR 2025

This session focuses on the management of complex left main trifurcation lesions. Review hybrid and double TAP techniques, long-term follow-up outcomes, and innovative approaches such as the inverted double TAP technique, offering insights into optimizing treatment strategies for these challenging anatomical scenarios.

Management of complex left main trifurcation lesion

Calcified nodules: a different beast?

21 May 2025 – From EuroPCR 2025

This session offers a comprehensive exploration of calcified nodules, a challenging entity in PCI. Learn to identify these nodules with IVUS and OCT, understand their unique treatment challenges, and select optimal plaque modification tools through detailed case discussions.

Calcified nodules: a different beast?

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

21 May 2025 – From EuroPCR 2025

This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

21 May 2025 – From EuroPCR 2025

Cerebral embolic protection (CEP) remains a key consideration in modern TAVI procedures, as stroke continues to be one of the most serious complications. This EuroPCR 2025 session takes a close look at the latest data on CEP use in clinical practice, weighing where it fits best...

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

Zero-contrast TAVI while using a novel full-body embolic protection filter

26 Nov 2024 – From PCR London Valves 2024

Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.

Zero-contrast TAVI while using a novel full-body embolic protection filter

Pushing the boundaries to optimise patient outcomes: from planning to success

26 Nov 2024 – From PCR London Valves 2024

Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.

Pushing the boundaries to optimise patient outcomes: from planning to success

From index procedure to re-valving with a novel self-expanding valve

25 Nov 2024 – From PCR London Valves 2024

Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...

From index procedure to re-valving with a novel self-expanding valve

Featured research - Aortic valve (Part 2)

24 Nov 2024 – From PCR London Valves 2024

This second part of the featured research session on aortic valve interventions delves into a wide range of topics, including vascular complications, valve-in-valve TAVI, coronary protection strategies, predictors of mortality, and innovative techniques. Discover the latest advancements and insights from cutting-edge research.

Featured research - Aortic valve (Part 2)

TAVI innovations: latest breakthroughs from PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.

Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...

TAVI innovations: latest breakthroughs from PCR London Valves 2024

Cardiogenic shock in women : different cause, different treatment

15 May 2024 – From EuroPCR 2024

This session will feature selected EuroPCR 2024 Clinical Case submissions focused on cardiogenic shock in women. Attendees will have the opportunity to learn about the proposed diagnoses and treatments, as well as the actual outcomes, for these challenging cases. The session will also include discussions and...

Cardiogenic shock in women : different cause, different treatment

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

15 May 2024 – From EuroPCR 2024

Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

TAVI - Durability and long-term outcomes

20 Nov 2023 – From PCR London Valves 2023

Consult this session to learn more about TAVI durability and long-term outcomes through a selection of abstracts: delve into a comprehensive five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis, navigate through the complexities of long-term outcomes associated with prosthesis-patient mismatch following valve-in-valve TAVI, explore...

TAVI - Durability and long-term outcomes

TAVI in complex scenarios - Bicuspid aortic valve disease - putting it all together

20 Nov 2023 – From PCR London Valves 2023

After an overview of what is currently known about TAVI in bicuspid aortic valves, follow the analysis of a real-life clinical case, and get tips on how to perform TAVI in a bicuspid aortic valve in 3 different ways: with a self-expanding supra-annular valve, using a...

TAVI in complex scenarios - Bicuspid aortic valve disease - putting it all together

TAVI in complex scenarios - Valve-in-valve TAVI (TAV-in-SAV) - A tailored approach

20 Nov 2023 – From PCR London Valves 2023

This session is designed for those seeking an understanding of critical imaging principles in planning successful TAV-in-SAV procedures. Gain insights into the latest tools for pre-procedural imaging and learn how to develop customized algorithms for selecting transcatheter heart valves in individual patients undergoing TAV-in-SAV interventions.

TAVI in complex scenarios - Valve-in-valve TAVI (TAV-in-SAV) - A tailored approach

TAVI outcomes - Part 1

19 Nov 2023 – From PCR London Valves 2023

Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...

TAVI outcomes - Part 1

Selecting the right first valve to secure lifetime management

17 May 2023 – From EuroPCR 2023

The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the...

EuroPCR 2023 Hotlines / Late-Breaking Trials: TAVI

16 May 2023 – From EuroPCR 2023

Discover the conclusions of various studies and registries about TAVI: 5-year outcomes with the ACURATE neo2 valve: the Neo AS CE-mark study; TAVR in patients with cardiogenic shock which evaluated outcomes of consecutive TAVRs in patients with CS using contemporary SAPIEN 3 and SAPIEN 3 ultra...

TAVI Hotlines EuroPCR2023

Ensuring optimal TAVI outcomes - LIVE case

27 Nov 2022 – From PCR London Valves 2022

A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...

Ensuring optimal TAVI outcomes

Valve-in-valve TAVI: session 1

27 Nov 2022 – From PCR London Valves 2022

ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!

Valve-in-valve TAVI: session 1